Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Gains from Investment Securities (2016 - 2025)

ImmunityBio (IBRX) has disclosed Gains from Investment Securities for 13 consecutive years, with $18.7 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 2831.04% to $18.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$57000.0 through Dec 2025, up 99.55% year-over-year, with the annual reading at $307000.0 for FY2025, 379.69% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $18.7 million at ImmunityBio, up from -$14.9 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $56.6 million in Q4 2023, with the low at -$31.3 million in Q3 2024.
  • Average Gains from Investment Securities over 5 years is $1.9 million, with a median of $20.0 recorded in 2021.
  • The sharpest move saw Gains from Investment Securities crashed 88359.09% in 2021, then skyrocketed 40233.33% in 2023.
  • Over 5 years, Gains from Investment Securities stood at -$19.5 million in 2021, then surged by 99.28% to -$141000.0 in 2022, then surged by 40233.33% to $56.6 million in 2023, then tumbled by 101.21% to -$683000.0 in 2024, then surged by 2831.04% to $18.7 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $18.7 million, -$14.9 million, and -$3.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.